Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Given Consensus Rating of “Buy” by Analysts
Shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) have been given an average rating of "Buy" by the ...
Read moreShares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) have been given an average rating of "Buy" by the ...
Read more© 2022 TheDailyStock.News